Furthermore, Yang et al. [80] observed that selective HDAC8 inhibition resulted in increased CD8+ T cell tumor infiltration in a preclinical model of hepatocellular carcinoma due to elevated production of T cell-recruiting chemokines. The gene discussed is HDAC8; the disease is hepatocellular carcinoma.